TGFβ1–TNFα-regulated secretion of neutrophil chemokines is independent of epithelial–mesenchymal transition in breast tumor cells
Molecular Biology of the Cell · 2025
DOI: 10.1091/mbc.e25-07-0340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology of the Cell, 2025. Verfasst von Shuvasree SenGupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109. Hauptthemen laut MEDLINE: Neutrophils, Tumor Necrosis Factor-alpha, Transforming Growth Factor beta1, Breast Neoplasms. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Neutrophils exert tumor-promoting roles in breast cancer and are particularly prominent in aggressive breast tumors. The proinflammatory signals TGF-β1 and TNF-α are upregulated in breast tumors and induce epithelial-to-mesenchymal transitions (EMT), a process linked to cancer cell aggressiveness. Here, we investigated the roles of TGF-β1 and TNF-α in the recruitment of neutrophils by breast cancer cells. Dual-treatment with TGF-β1 and TNF-α induces EMT signatures in premalignant M2 cells, which are part of the MCF10A breast cancer progression model. Conditioned media (CM) harvested from M2 cells treated with TGF-β1/TNF-α gives rise to amplified neutrophil chemotaxis compared with CM from vehicle-treated M2 cells. This response correlates with higher levels of the neutrophil chemokines CXCL1 and CXCL8, in a p38MAPK-dependent manner, and is attenuated by CXCL8-neutralizing antibodies. We combined gene editing, immunological, and biochemical assays to show that neutrophil recruitment and EMT are uncoupled in treated M2 cells. Finally, analysis of transcriptomic databases of cancer cell lines revealed a significant correlation between CXCL8 and TGF-β1/TNF-α–regulated or effector genes in breast cancer. These findings establish a novel role for the TGF-β1/TNF-α/p38 MAPK signaling axis in regulating neutrophil recruitment in breast cancer, independent of their profound impact on EMT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109.
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109.
- Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109.
- Undergraduate Research Opportunity Program, University of Michigan, Ann Arbor, MI 48109.
- Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109.
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI 48109.
ORCID-Profile: Pierre A Coulombe, Carole A Parent
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIAMS NIH HHS
Zitieren
APA
SenGupta, S., Cohen, E., Serrenho, J., Ott, K., Coulombe, P. A., & Parent, C. A. (2025). TGFβ1–TNFα-regulated secretion of neutrophil chemokines is independent of epithelial–mesenchymal transition in breast tumor cells. Molecular Biology of the Cell. https://doi.org/10.1091/mbc.e25-07-0340
Vancouver
SenGupta S, Cohen E, Serrenho J, Ott K, Coulombe PA, Parent CA. TGFβ1–TNFα-regulated secretion of neutrophil chemokines is independent of epithelial–mesenchymal transition in breast tumor cells. Molecular Biology of the Cell. 2025. doi:10.1091/mbc.e25-07-0340
BibTeX
@article{SenGupta2025,
author = {SenGupta, Shuvasree and Cohen, Erez and Serrenho, Joseph and Ott, Kaleb and Coulombe, Pierre A and Parent, Carole A},
title = {TGFβ1–TNFα-regulated secretion of neutrophil chemokines is independent of epithelial–mesenchymal transition in breast tumor cells},
journal = {Molecular Biology of the Cell},
year = {2025},
doi = {10.1091/mbc.e25-07-0340}
}
EUVIMED